Aarey Drugs & Pharmaceuticals Limited

AAREYDRUGS

INE198H01019

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 11:28:22 31/05/2024 BST			5-day change	1st Jan Change
46.62 ^INR	-2.90%		-5.24%	-7.74%

03-27	Aarey Drugs & Pharmaceuticals Limited announced that it has received INR 106.581598 million in funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited and other investors	CI
02-14	Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI

Aarey Drugs & Pharmaceuticals Limited Approves the Appointment of Mira M Ghatalia as an Chief Financial Officer

January 04, 2021 at 11:16 am

The Board of Directors of the Aarey Drugs & Pharmaceuticals Limited has approved the appointment of Mrs. Mira M Ghatalia with effect from 04.01.2021 as an Chief Financial Officer (CFO) on the Board of the Company.

Latest news about Aarey Drugs & Pharmaceuticals Limited

Aarey Drugs & Pharmaceuticals Limited announced that it has received INR 106.581598 million in funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited and other investors	03-26	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-14	CI
Aarey Drugs & Pharmaceuticals Limited Approves to Regularise the Appointment of Mrs. Bina Ghatalia as Non Executive Director	12-29	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-11	CI
Aarey Drugs & Pharmaceuticals Limited Announces Directorate Changes	09/10/23	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	14/08/23	CI
Aarey Drugs Board to Consider Raising Funds Via Equity, Warrants	27/07/23	MT
Aarey Drugs & Pharmaceuticals Limited announced that it expects to receive funding from Black Hawk Properties Private Limited, Rajan Dental Institute Private Limited, Marygold Health And Education Private Limited, Riddhi Trade Solutions Private Limited, Karan Monomer's Private Limited, Watco Chennai Real Estates Private Limited	25/07/23	CI
Worth Investment & Trading Company Limited announced that it expects to receive INR 201.15578 million in funding from a group of investors	18/07/23	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	29/05/23	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	08/02/23	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	14/11/22	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	13/08/22	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022	30/05/22	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	08/02/22	CI
Aarey Drugs & Pharmaceuticals' Board Allot 2 Million Equity Shares	25/11/21	MT
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	12/11/21	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	10/08/21	CI
Aarey Drugs & Pharmaceuticals Limited announced that it expects to receive INR 80.74 million in funding from Nimit Impex Pvt Ltd, Suraj Tradelinks Private Limited, and other investors	09/08/21	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	29/06/21	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	19/02/21	CI
Aarey Drugs & Pharmaceuticals Limited Approves the Appointment of Mira M Ghatalia as an Chief Financial Officer	04/01/21	CI
Aarey Drugs & Pharmaceuticals : CFO Tenders Resignation	07/12/20	MT
Aarey Drugs & Pharmaceuticals Limited Announces Resignation of Rajesh Pranlal Ghatalia, CFO	04/12/20	CI
Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/11/20	CI

Chart Aarey Drugs & Pharmaceuticals Limited

Duration

Period

Chart Aarey Drugs & Pharmaceuticals Limited

More charts

Company Profile

Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxaphylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Chlorinated Solvents, Industrial Intermediates, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.

Sector

Pharmaceuticals

Calendar

13/08/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
AAREY DRUGS & PHARMACEUTICALS LIMITED	-7.74%	15.67M
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B